2 Growth Stocks to Buy in the Tariff-Fueled Market Correction

Group 1: Market Outlook and Investment Strategy - During market downturns, panic selling is not advisable unless a company's investment thesis has changed due to recent developments [1] - Investors are encouraged to buy shares of top companies during market corrections, specifically mentioning Alphabet and DexCom as excellent growth-oriented options [2] Group 2: Alphabet (GOOG) - Alphabet's revenue is primarily derived from advertising, which may be negatively impacted by economic downturns and reduced ad budgets from consumers and businesses [3] - Despite short-term uncertainties, Alphabet's long-term prospects remain strong due to its dominance in search, cloud computing, AI, and video streaming [4] - The company generated significant ad revenue and its cloud and video streaming segments ended 2024 with a $110 billion annual run rate, surpassing initial expectations [5] - Alphabet benefits from a wide moat created by network effects and a strong brand, making it a top stock to consider during market corrections [6] Group 3: DexCom (DXCM) - DexCom may face rising costs and shrinking margins in the short term due to tariffs, but it continues to expand its manufacturing capabilities internationally [7] - The company is a leader in continuous glucose monitoring (CGM) systems, with significant growth potential driven by increased reimbursement coverage and market expansion [8][9] - There is still a large untapped market for CGM technology, with only about 1% of adults with diabetes worldwide having access to such devices [10] - DexCom's growth is supported by network effects, as a larger installed base encourages third-party companies to create compatible devices and accessories [12]